Mucolytic Gelomirtol (Respero Myrtol): method of application, actions, indications

Compound

GeloMyrtol® forte

GeloMyrtol®

Composition and release form

GELOMYRTOL
caps. enteric-sol. 120 mg blister, No. 10, No. 20

1 capsule contains standardized myrtol 120 mg.

Other Ingredients: Medium Chain Triglycerides;

shell: gelatin, glycerin 85%, dried substance of liquid sorbitol 70%, hydrochloric acid 13% (obtained from hydrochloric acid 25% and purified water), hypromellose phthalate, dibutyl phthalate.

GELOMIRTOL FORTE

caps. enteric-sol. 300 mg blister, No. 10, No. 20

1 capsule contains standardized myrtol 300 mg.

Other ingredients: refined rapeseed oil; shell: gelatin, glycerin 85%, dried substance of liquid sorbitol 70%, hydrochloric acid 13% (obtained from hydrochloric acid 25% and purified water), hypromellose phthalate, dibutyl phthalate.

Directions for use and doses

Orally, 30 minutes before meals, with a sufficient amount of water at room temperature.

GeloMyrtol® forte

Adults and children over 10 years old

Adults: for acute inflammation - 1 caps. 3–4 times a day; for chronic inflammation - 1 caps. 2 times a day; to facilitate sputum discharge in the morning - an additional 1 capsule. before bedtime.

Children from 10 to 18 years old: for acute inflammation - 1 caps. 2 times a day; for chronic inflammation - 1 caps. in a day.

The duration of treatment depends on the severity of the symptoms of the disease and is determined by the attending physician.

GeloMyrtol®

Adults and children over 6 years old

Adults: for acute inflammation - 2 caps. 4–5 times a day (8–10 capsules per day); for chronic inflammation - 2 caps. 3 times a day; to facilitate sputum discharge in the morning - an additional 2 caps. before bedtime (8 capsules per day).

Children from 6 to 10 years old: for acute inflammation - 1 caps. 3–4 times a day; for chronic inflammation - 1 caps. 2–3 times a day.

Children from 10 to 18 years old: for acute inflammation - 1 caps. 4–5 times a day; for chronic inflammation - 1 caps. 2–3 times a day.

The duration of treatment depends on the severity of the symptoms of the disease and is determined by the attending physician.

Gelomirtol Forte capsules 300 mg No. 20

Compound

The capsule contains:
Active ingredient:

myrtol standardized 300 mg for the minimum content: limonene 75 mg, cineole 75 mg, -pinene 20 mg,

Excipients:

rapeseed oil.

Capsule:

Gelatin, glycerol 85%, sorbitol, 13% hydrochloric acid solution.

Auxiliary components of the capsule shell:

hypromellose acetate succinate, triethyl citrate, sodium lauryl sulfate, talc, dextrin, ammonium glycyrrhizinate.

Pharmacokinetics

Well absorbed in the small intestine. The maximum concentration in blood plasma is achieved 1-3 hours after taking the drug. Approximately 60% of the drug and its metabolites are excreted in the urine, 5% in the feces, and about 2% in the lungs. Can penetrate the placental barrier into the milk of nursing women.

Indications for use

Used in complex therapy for acute and chronic bronchitis, for inflammation of the paranasal sinuses (sinusitis).

Contraindications

In case of accidental overdose, nausea, vomiting, convulsions are possible, and in severe cases, coma or breathing problems. In rare cases, after severe intoxication, disturbances in the functioning of the cardiovascular system are possible.

Treatment:

Vaseline oil in the amount of 3 ml per kilogram of body weight, gastric lavage with a 5% solution of sodium bicarbonate (baking soda), ventilation of the lungs with oxygen.

Directions for use and doses

The drug is taken orally in adults and children over 10 years of age half an hour before meals with a sufficient amount of cool water.

For adults

Prescribed for acute inflammation: 1 capsule 3-4 times a day, for chronic inflammation - 1 capsule 2 times a day. To facilitate mucus discharge in the morning, take an additional 1 capsule of the drug before bed.

Children from 10 to 18 years old

for acute inflammation, 1 capsule of the drug is prescribed 2 times a day, for chronic inflammation - 1 capsule per day.

The duration of treatment depends on the severity of the symptoms of the disease and is determined by the attending physician.

Storage conditions

In a dry place at a temperature not exceeding 25 C.

Keep out of the reach of children.

Best before date

3 years.

Do not take after expiration date.

Description

Soft gelatin capsules, transparent, oblong. The contents of the capsules are a clear, colorless liquid with a characteristic odor.

Conditions for dispensing from pharmacies

Over the counter

Dosage form

enteric capsules

Manufacturer and organization accepting consumer complaints

OJSC "Krasnogorskleksredstva" Russia,

143444, Moscow region, Krasnogorsk, microdistrict. Opalikha, st. Mira, 25

Tel.,

Fax

Email

https://www.krls.ru

Pharmacodynamics

It has anti-inflammatory, antibacterial, mucolytic effects.

Side effects

Allergic reactions are possible (itching, skin rash, facial swelling, bronchospasm), shortness of breath, tachycardia, dry mouth, stomach pain, flatulence, diarrhea, nausea, vomiting, increased mobility of kidney stones and gall bladder.

If side effects not listed in the instructions occur after taking the drug, you should immediately inform your doctor.

Use during pregnancy and breastfeeding

Due to the lack of special studies during pregnancy (II-III trimester), the drug should be taken with caution as prescribed by a doctor, provided that the expected benefit to the mother outweighs the potential risk to the fetus.

Interaction

Not described.

Overdose

In case of accidental overdose, nausea, vomiting, convulsions are possible, and in severe cases, coma or breathing problems. In rare cases, after severe intoxication, disturbances in the functioning of the cardiovascular system are possible.

Treatment:

Vaseline oil in the amount of 3 ml per kilogram of body weight, gastric lavage with a 5% solution of sodium bicarbonate (baking soda), ventilation of the lungs with oxygen.

special instructions

If the symptoms of the disease do not disappear or the patient’s condition worsens, shortness of breath appears, body temperature rises, blood or pus appears in the sputum, you should immediately consult a doctor.

Patients with asthma or whooping cough should consult a doctor before using the drug.

During pregnancy and breastfeeding. Although there is no information about the negative effects of the drug Gelomirtol on the fetus, during pregnancy and lactation it is taken only under the supervision of a doctor, especially in the first trimester.

Children. Gelomirtol is used in children aged from 3 years, and Gelomirtol forte - from 6 years.

Influence on reaction speed when driving vehicles and working with other mechanisms. No data.

Dosage

Gelomirtol and Gelomirtol forte capsules are recommended to be taken 30 minutes before meals with plenty of cold water or other drinks.

Gelomyrtol. In the clinical picture of an acute inflammatory disease, it is recommended to take 2 capsules of the drug Gelomirtol 4-5 times a day. In order to create conditions for improved sleep, the last dose should be taken before bedtime. For chronic inflammatory processes, 2 capsules of Gelomirtol are prescribed 3 times a day. The same dosage regimen is recommended for long-term therapy.

To facilitate morning mucus discharge in chronic bronchitis, it is recommended to take an additional 2 capsules of Gelomirtol before bedtime.

Children aged 3–10 years (this drug is prescribed to children at a time when they can swallow the capsule on their own) should be prescribed no more than half the recommended dose for adults. The drug is taken during the period of symptoms of the disease and for 2–4 days after their disappearance.

Gelomirtol forte. In case of clinical picture of acute inflammation, take 1 capsule 3-4 times a day. In order to create conditions for improved sleep, the last dose should be taken before bedtime.

For a chronic process, take 1 capsule 2 times a day. The same dosage is recommended for long-term therapy.

To facilitate morning mucus discharge in chronic bronchitis, it is recommended to take an additional 1 capsule of Gelomirtol Forte in the evening, before bed.

Children aged 6 to 10 years (this drug is prescribed to children at a time when they can swallow the capsule on their own) are prescribed 1 capsule 2 times a day.

The drug Gelomirtol and Gelomirtol Forte are taken during the period of symptoms of the disease and for 2-4 days after their disappearance.

Pharmaceutical action

expectorant. Gelomyrtol contains as an active substance an essential oil of plant origin - standardized myrtol.

Myrtol standardized has secretomotor and secretolytic effects, which contribute to the liquefaction of sputum, activation of the mucociliary epithelium and, as a result, intensive production of sputum. When used in high doses, standardized myrtol also has antimicrobial, immunomodulatory, antispasmodic and vasodilatory effects.

Pharmacokinetics have not been studied.

GeloMyrtol

GeloMyrtol is a natural expectorant. Used in the treatment of inflammatory diseases of the respiratory tract (inflammation of the paranasal sinuses, bronchi). In the structure of ENT pathology, inflammatory diseases account for about 90%, with the most common complication of acute respiratory infections being sinusitis. One of its signs is a pathological change in secretion. The secretion of the epithelium of the respiratory tract is one of the links in the mucociliary system, which, in turn, represents the first “line of defense” in the human body in the path of exogenous antigens. The presence of various protective factors in the secretion determines the biocenosis of the respiratory tract, external nose, nasal cavity, maxillary, frontal, sphenoid, and ethmoid sinuses. When inhaling, 60% of inhaled bacteria remain on the mucous membrane of the respiratory tract. The optimal physiological balance between the structure of the secretion and the functionality of the ciliated epithelium prevents excessive colonization of the respiratory tract by constantly inhaled microflora. The result of exposure to viral and bacterial agents is a change in the nature of the secretion and disruption of the transport of pathogenic agents by the mucociliary system. In this regard, one of the key aspects of the treatment of sinusitis is the use of drugs that change the characteristics of sputum - mucoregulators. One of these mucoregulators is GeloMyrtol, which combines the properties of a mucokinetic, mucus-thinning agent, antibacterial and anti-inflammatory drug.

The basis of the drug is a complex of essential oils. GeloMyrtol has passed all stages of clinical studies, in which its effectiveness and safety were confirmed. It has been used in Western European countries for more than four decades. After oral administration, essential oils are quickly absorbed from the gastrointestinal tract and enter the bloodstream, partially excreted through the respiratory tract. The drug improves the rheological properties of sputum, reducing its viscosity by shifting the pH to the alkaline side, thereby facilitating its evacuation from the bronchial tree. In addition, the drug has bacteriostatic and antifungal effects. GeloMyrtol is contraindicated in case of individual intolerance to the active and auxiliary components of the drug, cholelithiasis and urolithiasis, during pregnancy (1st trimester) and breastfeeding. In pediatric practice, GeloMyrtol is used starting from the age of 10. The optimal time to take it is half an hour before meals. single dose – 2 capsules (for adults), 1 capsule (for children). Frequency of administration – 4-5 times a day (for acute forms of the disease), 3 times a day (for chronic forms of the disease). The duration of the medication course is determined by the clinical picture and determined by the doctor. Possible undesirable side effects: allergic reactions, dyspepsia, exacerbation of urinary and cholelithiasis.

Note!

The description of the drug Gelomirtol on this page is a simplified author’s version of the apteka911 website, created on the basis of the instructions for use. Before purchasing or using the drug, you should consult your doctor and read the manufacturer's original instructions (attached to each package of the drug).

Information about the drug is provided for informational purposes only and should not be used as a guide to self-medication. Only a doctor can decide to prescribe the drug, as well as determine the dose and methods of its use.